Activated CD8+: Began Phase III trial

Applied Immune Sciences Inc. (AISX), Santa Clara, Calif. Product: Activated CD8+ tumor-infiltrating lymphocytes collected with the CELLector- CD8 device and expanded outside the body before reinfusion...